Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1621 1622 1623 1671 1672 1691 1692 1699 1765
This examiner grants 82% of resolved cases
Deborah D Carr works in Tech Center 1700 and Art Unit 1621. The examiner has a large dataset of 1073 resolved cases. The allowance rate is 81.8 percent, which is very high. This 81.8 percent rate suggests that the examiner frequently finds allowable subject matter and that applicants have a high probability of success.
The median days to allowance is 873. This is a fast timeline, with cases typically being allowed in a predictable period. The interview lift is 2.7 percent. This low lift suggests that interviews do not significantly change the outcome, likely because the allowance rate is already so high.
Practitioners in Art Unit 1621 can expect an efficient process given the 873 days to allowance. The 1073 resolved cases provide a robust statistical foundation for these metrics. While the 2.7 percent interview lift is minimal, the overall 81.8 percent allowance rate makes this a very favorable docket for patent applicants in Tech Center 1700.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18434869 | METHOD FOR PRODUCING 1,3-DISUBSTITUTED BICYCLO[1.1.1]PENTANE BY PHOTOREACTION | Non-Final OA | FUJIFILM Corporation |
| 18551704 | BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | Non-Final OA | ModernaTX, Inc. |
| 18700153 | METHOD FOR TREATING WASTEWATER OF NEOPENTYL GLYCOL | Non-Final OA | LG CHEM, LTD. |
| 18699478 | METHOD FOR PREPARING NEOPENTYL GLYCOL | Non-Final OA | LG CHEM, LTD. |
| 18689591 | METHOD FOR PRODUCING ACRYLIC ACID | Non-Final OA | LG CHEM, LTD. |
| 18292365 | PROCESS FOR THE CONTINUOUS DISTILLATION OF ACRYLATES | Non-Final OA | BASF SE |
| 18039501 | INTEGRATED PROCESS FOR THE PARALLEL PRODUCTION OF ALKALI METAL METHOXIDES | Final Rejection | BASF SE |
| 18697491 | METHOD OF PRODUCING ALKOXYLATED ETHER AMINES AND USES THEREOF | Non-Final OA | HUNTSMAN PETROCHEMICAL LLC |
| 18491438 | SYNERGISTIC ANTIFOULANT COMPOSITIONS AND METHODS OF USING THE SAME | Non-Final OA | ECOLAB USA Inc. |
| 18348074 | SYNERGISTIC ANTIFOULANT COMPOSITIONS AND METHODS OF USING THE SAME | Non-Final OA | Ecolab USA Inc. |
| 18256961 | PROCESS FOR PRODUCING PHOSGENE BY REACTION OF POLYCHLORINE ANIONS AND CARBON MONOXIDE | Non-Final OA | Covestro Deutschland AG |
| 18276314 | METHOD FOR PRODUCING ALKALI METAL/ALKALINE EARTH METAL HYDROXIDE AND APPLICATION OF SAID PRODUCTION METHOD TO CARBOXYLATE WASTE RECYCLING TECHNOLOGY | Non-Final OA | TOHOKU UNIVERSITY |
| 18259792 | METHOD FOR PREPARING ISOCYANATE COMPOUND | Final Rejection | Hanwha Solutions Corporation |
| 18419693 | METHOD FOR THE PREPARATION OF ALKENYL HALIDES | Non-Final OA | Chevron Phillips Chemical Company LP |
| 18284962 | STABILIZED BORON ANIONS | Non-Final OA | UNIVERSITY OF VIRGINIA PATENT FOUNDATION |
| 18513001 | DISILYLAMINE PRECURSORS AND RELATED METHODS | Non-Final OA | ENTEGRIS, INC. |
| 18551619 | METHODS FOR PRODUCING OF LIPIDS | Non-Final OA | Pfizer Inc. |
| 18794166 | DERMATOLOGIC TOPICAL APPLICATIONS OF ROR GAMMA AND ROR GAMMA-T INHIBITORS FOR THE PREVENTION OF SKIN CANCER DEVELOPMENT | Non-Final OA | Yale University |
| 18558447 | RECYCLED CONTENT DIOCTYL TEREPHTHALATE | Final Rejection | Eastman Chemical Company |
| 18546868 | REMOVAL OF UNWANTED MINERAL OIL HYDROCARBONS | Final Rejection | CARGILL, INCORPORATED |
| 18698828 | PROCESS FOR METHYL METHACRYLATE PRODUCTION FROM ETHANOL | Non-Final OA | Rohm and Haas Company |
| 18265366 | IONIZABLE LIPIDS | Non-Final OA | Universiteit Gent |
| 17777402 | Processes for the Preparation of Alpha-Hydroxy Esters via Grignard Coupling and Thiolation Reactions | Non-Final OA | Kemin Industries, Inc. |
| 18270843 | METHODS OF PRODUCING LOW-ACETAL ETHANOL | Non-Final OA | SUPERBREWED FOOD, INC. |
| 18016909 | POLYETHYLENE GLYCOL CONJUGATE DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | CHONGQING UPGRA BIOTECHNOLOGY CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy